Proteoglycan,
does it really help with Skin and joints?
research showsSmall human trials of proteoglycan derived from salmon nasal cartilage are mentioned in the context of Japanese functional foods, but publicly searchable sources did not provide enough independently verifiable RCT evidence with author, year, primary endpoint, effect size, and funding source. I do not grade the skin and joint claims upward and leave the judgment deferred.
ads claimAdvertisements mention 'salmon nasal cartilage,' 'proteoglycan,' 'joint cushioning,' and 'skin moisture/elasticity.' Verifiable public evidence remains at the level of biological explanations or studies of related ingredients.
Useful facts when choosing a product
- Proteoglycan is a component of articular cartilage, but that does not mean it is delivered unchanged to the target tissue after ingestion.
- Because it is a fish-derived ingredient, fish allergy and quality standardization are important.
- Evidence for chondroitin, collagen, or hyaluronic acid was not applied unchanged to this ingredient.
- No score is assigned until the original human RCT text is verified.
What the research actually shows
In searchable English-language and public databases, it was difficult to reliably reproduce and verify RCTs of a single salmon nasal cartilage proteoglycan ingredient for skin and joints. There are large chondroitin/glucosamine studies in the joint field, but the ingredient, structure, and dose differ, so they were not directly transferred. Therefore, the judgment is deferred with the human efficacy evidence effectively unconfirmed.
Why this is classified as ?
Because the existence and content of direct human RCTs could not be sufficiently verified, the judgment is ? / Judgment deferred.
Counterpoint. If Japanese original RCTs and funding sources are obtained, this could be reassessed as C or at the B/C boundary.
Rejudgment record. Draft — Because the existence and content of direct human RCTs could not be sufficiently verified, the judgment is ? / Judgment deferred.
Cross-check — Codex and Claude
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Study 1 | Literature verification | Direct RCTs for skin and joints | Sufficient independently verifiable public RCT information was not obtained. | Core | ||
| Clegg DO et al. 2006 | Large randomized trial | 1,583 | NIH | Knee osteoarthritis pain | This is a study of related cartilage ingredients, glucosamine/chondroitin, but it is not direct evidence for the proteoglycan ingredient. | Background |
Receipt — 2 References
Every cited source was opened and checked against the live page on 2026-07-10.
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-10 · Corrections: none
Cite this verdict
[Chamgap] Proteoglycan (from Salmon Nasal Cartilage) × Skin and Joints — Evidence Grade ?. 2 cited sources checked. Source: https://health-receipt.pages.dev/en/verdicts/skin-hair/salmon-proteoglycan-skin-joint/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.